SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: fred hayes who wrote (3481)11/1/2002 11:41:22 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 10345
 
Fred:

As you know, ELN used to have a market cap of $20 billion.

You're asking questions that largely relates to "book". And, as all of us have observed, "book" is being written off, rapidly.

I'd therefore suggest that you direct your valuation questions to those investors who believed in ELN at that $20 billion cap. Look for those who were contributing to this thread, 6/01. They'll certainly have the long-term perspective re. facilities and the like. They'll certainly have all the answers.

Correct?

finance.yahoo.com

Many of us newer investors are classic biotech speculators, betting that upside leverage re. Antegren -- and some retained gems -- dictates that ELN belongs in a balanced basket of leveraged business plans.

Good luck!

Rick